BrainIAC, a new foundation model from Mass General Brigham, outperforms traditional AI approaches in analyzing brain MRI for tasks like brain age estimation and cancer prognosis.
Key Details
- 1BrainIAC was pretrained on nearly 49,000 brain MRI scans using self-supervised learning.
- 2Validated across seven diverse clinical MRI tasks, including brain age, dementia risk, tumor mutation detection, and survival prediction.
- 3Outperformed three conventional, task-specific AI models, especially in scenarios with limited labeled data.
- 4Demonstrated strong generalizability across healthy and diseased cases as well as different MRI types.
- 5Study published in Nature Neuroscience, developed by Mass General Brigham, and funded by NIH/NCI among others.
Why It Matters
This work introduces a flexible, generalizable AI tool that could streamline the adoption of imaging AI in clinical practice, particularly where annotated data is limited. BrainIAC's ability to perform well across a range of complex imaging tasks may help accelerate personalized medicine and clinical decision making in neuroradiology.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.